4hon MSN
After new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses
The experimental drug daraxonrasib, which doubled survival time in patients with advanced pancreatic cancer, may also prove effective for lung, colon and ovarian cancers.
Scientists have uncovered a surprising navigation system in pigeons: iron-filled immune cells in the liver that may act like ...
Researchers added paricalcitol to chemotherapy and assessed outcomes in metastatic pancreatic cancer. The treatment remodeled ...
Fatty liver disease, now called MASLD, is increasingly linked to liver cancer due to long-term inflammation and liver cell ...
Preclinical studies at the Salk Institute laid the foundation for a question now being tested in patients: Can a vitamin ...
The highly anticipated results of a clinical trial for the pill, daraxonrasib, have been released, giving doctors hope for ...
A small clinical trial led by Dana-Farber Cancer Institute researchers put a Salk Institute idea to the test in patients: that ...
A small clinical trial led by Dana-Farber Cancer Institute researchers put a Salk Institute idea to the test in patients: ...
A small clinical trial led by Dana-Farber Cancer Institute researchers has put a Salk Institute idea to the test in patients: ...
Indore (Madhya Pradesh): Rapid advancements in medical technology are transforming complex liver and pancreas surgeries, making them safer, more precise, and less risky for patients. Experts from ...
Pemvidutide improves fibrosis markers, liver fat, lipids, weight, and blood pressure in patients with MASH at 1 year, phase 2b data show.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results